Revises provisions relating to kratom products. (BDR 52-763)

AB 322 requires all kratom products containing the alkaloid mitragynine (or its synthetic equivalents) to be registered with Nevada's Division of Public and Behavioral Health before being sold to end users. Sellers must pay fees, submit laboratory testing reports (including FDA-mandated data), and follow new labeling requirements. The bill replaces existing $1,000 civil penalties with administrative fines for violations and exempts registered sellers from criminal penalties if mitragynine is later classified as a controlled substance under state law. This directly affects kratom sellers, the health division, and consumers seeking regulated products.